KS
About
Ken Song is the President and CEO,and Board Member of Metacrine. My experience spans clinical medicine, basic science research, venture capital, and entrepreneurship. Prior to joining Metacrine, I was the co-founder and CEO of Ariosa Diagnostics from 2010 to 2016.
Position in the VCSift Database
- • 2 investors at Ablaze Pharmaceuticals are tracked.
- • 2 investors hold the Chairman of the Board and Co-founder role in VCSift. Ken Song is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Ken
Search Investors